S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Did You Get Your Free Bitcoin Yet? (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
How Biden has already won 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Did You Get Your Free Bitcoin Yet? (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
How Biden has already won 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Did You Get Your Free Bitcoin Yet? (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
How Biden has already won 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Did You Get Your Free Bitcoin Yet? (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
How Biden has already won 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial

BridgeBio Pharma (BBIO) Earnings Date, Estimates & Call Transcripts

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free bbio Stock Alerts
$24.74
-0.21 (-0.84%)
(As of 04/19/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 2Estimated
Actual EPS
(Feb. 22)
-$0.96 Missed By -$0.09
Consensus EPS
(Feb. 22)
-$0.87
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

BBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BBIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BridgeBio Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.84)$0.44($0.20)
Q2 20242($0.92)($0.84)($0.88)
Q3 20242($0.95)($0.81)($0.88)
Q4 20242($0.97)($0.82)($0.90)
FY 20248($3.68)($2.03)($2.86)

BBIO Earnings Date and Information

BridgeBio Pharma last released its quarterly earnings data on February 22nd, 2024. The reported ($0.96) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.87) by $0.09. The company earned $1.74 million during the quarter, compared to analyst estimates of $4.78 million. Its revenue for the quarter was down 8.4% on a year-over-year basis. BridgeBio Pharma has generated ($3.94) earnings per share over the last year (($3.94) diluted earnings per share). Earnings for BridgeBio Pharma are expected to grow in the coming year, from ($3.09) to ($2.76) per share. BridgeBio Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.

BridgeBio Pharma Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Estimated)		------- 
2/22/2024Q4 2023($0.87)($0.96)($0.09)($0.96)$4.78 million$1.74 million
11/2/2023Q3 2023($0.86)($1.08)($0.22)($1.08)$5.29 million$4.09 million
8/3/2023Q2 2023($0.80)($0.98)($0.18)($0.98)$2.99 million$1.60 million
5/4/2023Q1 2023($0.83)($0.92)($0.09)($0.92)$3.23 million$1.83 million
2/23/2023Q4 2022($0.86)($0.87)($0.01)($0.82)$12.24 million$1.87 million
11/3/2022Q3 2022($1.02)($0.93)+$0.09($0.93)$6.26 million$0.34 million
8/4/2022Q2 2022($0.92)($0.81)+$0.11($1.55)$29.96 million$73.75 million
5/5/2022Q1 2022($1.13)($1.19)($0.06)($1.03)$4.47 million$1.69 million
2/24/2022Q4 2021($0.83)($1.01)($0.18)($1.01)$21.58 million$12.89 million    
11/4/2021Q3 2021($0.91)($1.06)($0.15)($1.06)$16.12 million$2.34 million
8/5/2021Q2 2021($0.97)($0.66)+$0.31($0.66)$24.93 million$54.00 million
5/6/2021Q1 2021($0.83)($1.18)($0.35)($1.18)$21.91 million$0.46 million  

BridgeBio Pharma Earnings - Frequently Asked Questions

When is BridgeBio Pharma's earnings date?

BridgeBio Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on BBIO's earnings history.

Did BridgeBio Pharma beat their earnings estimates last quarter?

In the previous quarter, BridgeBio Pharma (NASDAQ:BBIO) missed the analysts' consensus estimate of ($0.87) by $0.09 with a reported earnings per share (EPS) of ($0.96). Learn more on analysts' earnings estimate vs. BBIO's actual earnings.

How much revenue does BridgeBio Pharma generate each year?

BridgeBio Pharma (NASDAQ:BBIO) has a recorded annual revenue of $9.30 million.

How much profit does BridgeBio Pharma generate each year?

BridgeBio Pharma (NASDAQ:BBIO) has a recorded net income of -$643.20 million. BBIO has generated -$3.94 earnings per share over the last four quarters.

What is BridgeBio Pharma's EPS forecast for next year?

BridgeBio Pharma's earnings are expected to grow from ($3.09) per share to ($2.76) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:BBIO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Urgent alert: open this for a huge profit potential
Timothy Sykes